Related Experiment Video

Updated: Aug 8, 2026

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease
08:05

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease

Published on: March 17, 2020

The cancer and leukemia group B transplant committee

Charles Linker1, David Hurd

  • 1University of California at San Francisco, San Francisco, California and Wake Forest, Winston-Salem, North Carolina, USA. linkerc@medicine.ucsf.edu

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|June 3, 2006
PubMed

Insights

The Cancer and Leukemia Group B Transplant Committee advances hematologic malignancy treatment through collaborative studies. Their research defines roles for autologous and allogeneic transplantation, potentially changing standards of care.

Area of Science:

  • Hematology
  • Oncology
  • Transplantation Medicine

Background:

  • The Cancer and Leukemia Group B (CALGB) Transplant Committee possesses a strong research portfolio.
  • Collaboration is key to advancing the field of transplantation for hematologic malignancies.

Purpose of the Study:

  • To define the roles of autologous and reduced-intensity allogeneic transplantation in managing hematologic malignancies.
  • To identify potential changes to the standard of care in transplant-related therapies.

Main Methods:

  • Conducting collaborative studies within the CALGB framework.
  • Working with Leukemia and Lymphoma Disease Committees and external groups.

Main Results:

  • Studies are underway to evaluate maintenance therapy for multiple myeloma post-autologous transplantation.
  • Research aims to generate data supporting new post-remission therapy approaches for older acute myeloid leukemia patients.

Conclusions:

  • Cooperative group studies demonstrate the feasibility and generalizability of successful transplant approaches.
  • The committee's work is poised to make significant contributions to the field of hematologic stem cell transplantation.

More Related Videos

A Neonatal Intravenous Transplant Model for Assessment of Early-Life Immune Activities Against Cancer Cells06:32

A Neonatal Intravenous Transplant Model for Assessment of Early-Life Immune Activities Against Cancer Cells

Published on: June 26, 2026

Related Concept Videos

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...